Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1853 1
1873 1
1883 1
1884 1
1885 1
1898 1
1902 1
1903 1
1907 1
1908 1
1909 1
1911 1
1912 1
1914 1
1915 1
1918 3
1919 1
1921 2
1925 2
1927 1
1929 1
1935 1
1946 16
1947 7
1948 10
1949 9
1950 9
1951 13
1952 11
1953 12
1954 8
1955 4
1956 9
1957 9
1958 11
1959 6
1960 7
1961 7
1962 6
1963 11
1964 6
1965 11
1966 11
1967 13
1968 14
1969 8
1970 17
1971 13
1972 14
1973 20
1974 15
1975 15
1976 19
1977 20
1978 12
1979 22
1980 18
1981 31
1982 29
1983 42
1984 52
1985 48
1986 64
1987 55
1988 58
1989 80
1990 71
1991 65
1992 67
1993 93
1994 99
1995 113
1996 123
1997 100
1998 102
1999 114
2000 128
2001 154
2002 134
2003 153
2004 157
2005 177
2006 190
2007 186
2008 219
2009 222
2010 239
2011 260
2012 276
2013 300
2014 339
2015 371
2016 360
2017 372
2018 319
2019 313
2020 328
2021 383
2022 314
2023 279
2024 310
2025 324
2026 49

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

7,911 results

Results by year

Filters applied: . Clear all
Page 1
Cellular ATP demand creates metabolically distinct subpopulations of mitochondria.
Ryu KW, Fung TS, Baker DC, Saoi M, Park J, Febres-Aldana CA, Aly RG, Cui R, Sharma A, Fu Y, Jones OL, Cai X, Pasolli HA, Cross JR, Rudin CM, Thompson CB. Ryu KW, et al. Among authors: thompson cb. Nature. 2024 Nov;635(8039):746-754. doi: 10.1038/s41586-024-08146-w. Epub 2024 Nov 6. Nature. 2024. PMID: 39506109 Free PMC article.
Integrated multimodal cell atlas of Alzheimer's disease.
Gabitto MI, Travaglini KJ, Rachleff VM, Kaplan ES, Long B, Ariza J, Ding Y, Mahoney JT, Dee N, Goldy J, Melief EJ, Agrawal A, Kana O, Zhen X, Barlow ST, Brouner K, Campos J, Campos J, Carr AJ, Casper T, Chakrabarty R, Clark M, Cool J, Dalley R, Darvas M, Ding SL, Dolbeare T, Egdorf T, Esposito L, Ferrer R, Fleckenstein LE, Gala R, Gary A, Gelfand E, Gloe J, Guilford N, Guzman J, Hirschstein D, Ho W, Hupp M, Jarsky T, Johansen N, Kalmbach BE, Keene LM, Khawand S, Kilgore MD, Kirkland A, Kunst M, Lee BR, Leytze M, Mac Donald CL, Malone J, Maltzer Z, Martin N, McCue R, McMillen D, Mena G, Meyerdierks E, Meyers KP, Mollenkopf T, Montine M, Nolan AL, Nyhus JK, Olsen PA, Pacleb M, Pagan CM, Peña N, Pham T, Pom CA, Postupna N, Rimorin C, Ruiz A, Saldi GA, Schantz AM, Shapovalova NV, Sorensen SA, Staats B, Sullivan M, Sunkin SM, Thompson C, Tieu M, Ting JT, Torkelson A, Tran T, Valera Cuevas NJ, Walling-Bell S, Wang MQ, Waters J, Wilson AM, Xiao M, Haynor D, Gatto NM, Jayadev S, Mufti S, Ng L, Mukherjee S, Crane PK, Latimer CS, Levi BP, Smith KA, Close JL, Miller JA, Hodge RD, Larson EB, Grabowski TJ, Hawrylycz M, Keene CD, Lein ES. Gabitto MI, et al. Among authors: thompson c. Nat Neurosci. 2024 Dec;27(12):2366-2383. doi: 10.1038/s41593-024-01774-5. Epub 2024 Oct 14. Nat Neurosci. 2024. PMID: 39402379 Free PMC article.
Metabolic adaptations direct cell fate during tissue regeneration.
Chaves-Perez A, Millman SE, Janaki-Raman S, Ho YJ, Hinterleitner C, Barthet VJA, Morris JP 4th, Barriga FM, Reyes J, Kyaw A, Pasolli HA, Pe'er D, Thompson CB, Finley LWS, Cross JR, Lowe SW. Chaves-Perez A, et al. Among authors: thompson cb. Nature. 2025 Jul;643(8071):468-477. doi: 10.1038/s41586-025-09097-6. Epub 2025 Jun 11. Nature. 2025. PMID: 40500453 Free PMC article.
Metabolic engineering to facilitate anti-tumor immunity.
Schild T, Wallisch P, Zhao Y, Wang YT, Haughton L, Chirayil R, Pierpont K, Chen K, Nunes-Violante S, Cross J, de Stanchina E, Thompson CB, Scheinberg DA, Perry JSA, Keshari KR. Schild T, et al. Among authors: thompson cb. Cancer Cell. 2025 Mar 10;43(3):552-562.e9. doi: 10.1016/j.ccell.2025.02.004. Epub 2025 Feb 27. Cancer Cell. 2025. PMID: 40020672
Early influenza virus characterisation and vaccine effectiveness in England in autumn 2025, a period dominated by influenza A(H3N2) subclade K.
Kirsebom FC, Thompson C, Talts T, Kele B, Whitaker HJ, Andrews N, Abdul Aziz N, Rawlinson C, Green RE, Quinot C, Gardner N, Waller E, Allen A, Watson CH, McDonald SL, Zambon M, Pebody R, Ramsay M, Hoschler K, Singanayagam A, Lopez Bernal J. Kirsebom FC, et al. Among authors: thompson c. Euro Surveill. 2025 Nov;30(46):2500854. doi: 10.2807/1560-7917.ES.2025.30.46.2500854. Euro Surveill. 2025. PMID: 41267661 Free PMC article.
Arginine: at the crossroads of nitrogen metabolism.
Fung TS, Ryu KW, Thompson CB. Fung TS, et al. Among authors: thompson cb. EMBO J. 2025 Mar;44(5):1275-1293. doi: 10.1038/s44318-025-00379-3. Epub 2025 Feb 7. EMBO J. 2025. PMID: 39920310 Free PMC article. Review.
Engineered deletions of HIV replicate conditionally to reduce disease in nonhuman primates.
Pitchai FNN, Tanner EJ, Khetan N, Vasen G, Levrel C, Kumar AJ, Pandey S, Ordonez T, Barnette P, Spencer D, Jung SY, Glazier J, Thompson C, Harvey-Vera A, Son HI, Son HI, Strathdee SA, Holguin L, Urak R, Burnett J, Burgess W, Busman-Sahay K, Estes JD, Hessell A, Fennessey CM, Keele BF, Haigwood NL, Weinberger LS. Pitchai FNN, et al. Among authors: thompson c. Science. 2024 Aug 9;385(6709):eadn5866. doi: 10.1126/science.adn5866. Epub 2024 Aug 9. Science. 2024. PMID: 39116226 Free PMC article.
Engineering mtDNA deletions by reconstituting end joining in human mitochondria.
Fu Y, Land M, Kavlashvili T, Cui R, Kim M, DeBitetto E, Lieber T, Ryu KW, Choi E, Masilionis I, Saha R, Takizawa M, Baker D, Tigano M, Lareau CA, Reznik E, Sharma R, Chaligne R, Thompson CB, Pe'er D, Sfeir A. Fu Y, et al. Among authors: thompson cb. Cell. 2025 May 15;188(10):2778-2793.e21. doi: 10.1016/j.cell.2025.02.009. Epub 2025 Mar 10. Cell. 2025. PMID: 40068680
Safety and activity of tarlatamab in combination with a PD-L1 inhibitor as first-line maintenance therapy after chemo-immunotherapy in patients with extensive-stage small-cell lung cancer (DeLLphi-303): a multicentre, non-randomised, phase 1b study.
Paulson KG, Lau SCM, Ahn MJ, Moskovitz M, Pogorzelski M, Häfliger S, Parkes A, Zhang Y, Hamidi A, Thompson CG, Wermke M. Paulson KG, et al. Among authors: thompson cg. Lancet Oncol. 2025 Oct;26(10):1300-1311. doi: 10.1016/S1470-2045(25)00480-2. Epub 2025 Sep 8. Lancet Oncol. 2025. PMID: 40934933 Clinical Trial.
7,911 results